This section of Viatris.com contains information that may not be suitable for use in all countries due to varied regulatory requirements, data protection requirements and practices or medical practices, and distinctions among product approval and commercial availability.
- Apr 8, 2021
One of the most effective interventions in public health is Pre-Exposure Prophylaxis (PrEP) for HIV. Viatris is proud to offer a generic form of a PrEP treatment in the U.S. with the goal of expanding access for the at-risk population.
- Apr 7, 2021
At Viatris, we are reimagining healthcare not as it is, but as it should be.
- Mar 22, 2021
On World TB Day, we reflect on the progress made and need to do more in the fight against drug-resistant TB.
- Mar 1, 2021
Highlighting a strong foundation and clear roadmap for the future at our inaugural Investor Day, Viatris leaders showcased our journey to build a new kind of healthcare company.
- Feb 10, 2021
The diverse perspectives of our colleagues help drive innovation so that we can empower people everywhere to live healthy at every stage of life.